Completed PHASE4 INTERVENTIONAL 1-arm NCT04218799

Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans

Sponsor: University of Maryland, Baltimore

Interventions Intranasal Mupirocin and Topical Chlorhexidine

Updated 8 times since 2020 Last updated: Jun 5, 2023 Started: Aug 12, 2014 Primary completion: Sep 22, 2015 Completion: Sep 22, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Human Microbiome, this trial is completed. The trial is conducted by University of Maryland, Baltimore and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jul 2023 — Jul 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2023 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE4
May 2020 — Jan 2021 [monthly]

Completed PHASE4
Feb 2020 — May 2020 [monthly]

Completed PHASE4

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Maryland, Baltimore
VA Office of Research and Development

Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States
• Perry Point, United States